2024
Benjamin ESathya Bam, Vinod E, Illangeswaran RStephen St, Rajamani BM, Vidhyadharan RThalayattu, Bagchi A, Maity A, Mohan A, Parasuraman G, Amirtham SManickam, Abraham A, Velayudhan SR, Balasubramanian P.
2024. Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.. Cell Signal. 116:111067. DOI:10.1016/j.cellsig.2024.111067.
2023
Rajamani BM, Illangeswaran RStephen St, Benjamin ESathya Bam, Balakrishnan B, Jebanesan DZechariah, Das S, Pai AAnand, Vidhyadharan RThalayattu, Mohan A, Karathedath S, Abraham A, Mathews V, Velayudhan SR, Balasubramanian P.
2023. Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib and reduces disease burden .. Front Pharmacol. 14:1187066. DOI:10.3389/fphar.2023.1187066.
2022
Daniel HD-J, Kumar S, Kannangai R, J F, Joel JN, Abraham A, Lakshmi KM, Agbandje-McKenna M, Coleman KE, Srivastava A, Srivastava A, Abraham AM.
2022. Age-stratified adeno-associated virus serotype 3 neutralizing and total antibody prevalence in hemophilia A patients from India.. J Med Virol. 94(9):4542-4547. DOI:10.1002/jmv.27859.